Bhupesh K. Goyal
Bhadson Road
Patiala, PB 147004, India
Patiala, PB 147004, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Leveraging molecular dynamics to unravel the inhibition mechanism of potential β-secretase (BACE1) inhibitors.
Journal: Physical chemistry chemical physics : PCCP
Published: August 05, 2026
Macrocyclic peptides and peptidomimetics as modulators of protein-protein interactions.
Journal: RSC medicinal chemistry
Published: July 16, 2026
Mechanistic insights into the inhibition of hIAPP fibrillation by amyloidogenic core-derived peptide NFGAILSS using computer simulations.
Journal: Physical chemistry chemical physics : PCCP
Published: April 16, 2026
Mutations in the Aβ42 Recognition Sequence KLVFF Afford New Pentapeptide Inhibitors of Aβ42 Fibrillation: Computation-Driven Rational Design and Experimental Validation.
Journal: The journal of physical chemistry. B
Published: January 21, 2026
Synergistic Effect of Mutations in the Amyloidogenic Core of Human Amylin (hAM) Affords a New Potent Inhibitor of hAM Fibrillation: Computational Design and Experimental Validation.
Journal: ACS chemical neuroscience
Published: January 12, 2026
Ligand-based virtual screening to discover potential inhibitors of SARS-CoV-2 main protease.
Journal: Physical chemistry chemical physics : PCCP
Published: September 03, 2025
The Synergistic Potential of Rationally Designed Phenol-Triazole Derivatives to Attenuate Aβ/Cu2+-Aβ Aggregation and Reactive Oxygen Species.
Journal: ACS chemical neuroscience
Published: July 25, 2025
Modulation of hIAPP Fibrillation by Rationally Designed Hexapeptides Revealed by Molecular Dynamics and Experimental Investigations.
Journal: ACS chemical neuroscience
Published: June 16, 2025
Delineating the tryptophan-galactosylamine conjugate mediated structural distortions in Aβ42 protofibrils.
Journal: Physical chemistry chemical physics : PCCP
Published: March 24, 2025
Structural Reorganization Mechanism of the Aβ42 Fibril Mediated by N-Substituted Oligopyrrolamide ADH-353.
Journal: ACS chemical neuroscience
Published: August 19, 2024
Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer's Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress.
Journal: ACS chemical neuroscience
Published: July 09, 2024
Last Updated: 09/26/2026